DEC 05, 2018 08:00 PM PST

The Use of Flow Cytometry to Identify Cancer Stem Cells in Primary Tumors and in Circulation

SPONSORED BY: Thermo Fisher Scientific
C.E. CREDITS: P.A.C.E. CE | Florida CE
Speakers
  • Ramón y Cajal Investigator, Autónoma University of Madrid, School of Medicine, Instituto de Investigaciones Biomédicas "Alberto Sols" CSIC-UAM
    Biography
      Dr. Bruno Sainz is a Ramón y Cajal Researcher, with co-appointments in the Department of Biochemistry at the Autónoma University of Madrid, the Department of Cancer Biology at the Instituto de Investigaciones Biomédicas "Alberto Sols" CSIC-UAM and in the Chronic Diseases and Cancer Area of the Ramón y Cajal Institute for Health Research. Dr. Sainz obtained his PhD in Microbiology and Immunology from Tulane University in 2005, and began working on cancer in 2011 after joining the Spanish National Cancer Research Centre as a Staff Scientist. He currently heads the Cancer Stem Cells and Tumor Microenvironment group, focusing on the study of cancer stem cells (CSCs) and the fibroinflammatory microenvironment in pancreatic ductal adenocarcinoma (PDAC). His lab is running a combined basic and translation research program, which synergistically combines studies on the biology of mouse and human CSCs, including their in vivo microenvironment, in order to enhance our understanding of the regulatory machinery of CSCs. Specifically, his laboratory is pursuing: 1) The identification and characterization of new biomarkers for the detection of CSCs from different solid tumors; 2) The identification of proteins that govern key CSC phenotypes, such as "stemness", epithelial to mesenchymal transition (EMT), oxidative phosphorylation and chemoresistance; and 3)Comprehensive understanding of the cellular make-up of the CSC niche and the more complex tumor microenvironment, specifically the role of tumor-associated macrophages (TAMs) in promoting CSCs, with respect to the different environmental proteins they can secrete in response to cues from the tumor and how these proteins alter the function of the CSCs at the level of EMT and chemoresistance. The group is using state of the art in vitro (primary PDAC cultures) and in vivo (patient-derived xenograft and genetically engineered mouse models) systems along with acoustic flow cytometry, to better understand the role of CSCs in cancer.

    Abstract:

    DATE: December 05, 2018
    TIME:  08:00pm PST

    What is desperately needed are methods to detect cells that cause metastasis–known as cancer stem cells (CSC), a subpopulation of tumor cells with “stem” like, chemoresistant and unlimited self-renewal properties. This webinar will discuss the advancements in the detection of CSCs in primary tumors and in circulation using acoustic flow cytometry together with a new CSC marker, autofluorescence and other CSC markers.

    Learning Objectives:

    •  How cancer stem cells can be identified using flow cytometry
    •  What factors that should be considered when using flow cytometry to identify cells from tumors and from blood
    • About sample preparation and choosing CSC markers

    Show Resources
    You May Also Like
    JUN 05, 2019 05:00 PM CEST
    C.E. CREDITS
    JUN 05, 2019 05:00 PM CEST
    DATE: June 5, 2019TIME: 8:00am PDT, 11:00am EDT, 5:00pm CEST Eukaryotic cell cultures respond to the most subtle influence. Apart from the risk of contamination, minimal chan...
    NOV 18, 2019 08:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    NOV 18, 2019 08:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE: November 18, 2019TIME: 8:00am PST, 11:00am EST, 4:00pm CEWT How often do you pipette in your cell culture lab every day? Usually, we do it so often that we tend stop th...
    SEP 05, 2019 04:00 PM CEST
    C.E. CREDITS
    SEP 05, 2019 04:00 PM CEST
    DATE: September 5, 2019TIME: 7:00am PT, 10:00am ET, 4:00pm CEST PCR (Polymerase Chain Reaction) has gone through a massive evolution since its development in 1983. Besides it...
    AUG 27, 2019 09:00 AM PDT
    C.E. CREDITS
    AUG 27, 2019 09:00 AM PDT
    DATE: August 27, 2019 TIME: 9:00am PDT, 12:00pm EDT Immunotherapies targeting PD-1 or PD-L1 have proven remarkably effective for treating cancer in some patients, with considerabl...
    MAY 16, 2019 04:00 PM CEST
    C.E. CREDITS
    MAY 16, 2019 04:00 PM CEST
    DATE: May 16, 2019TIME: 7:00am PDT, 10:00am EDT, 4:00pm CEST The emergence of NGS is revolutionizing the microbiological sciences and transforming medicine. Deep sequencing has...
    JUN 19, 2019 10:00 AM PDT
    JUN 19, 2019 10:00 AM PDT
    DATE: June 19, 2019TIME: 10:00am PDT, 1:00pm EDT As we develop new methods to create more biologically relevant models for research in understanding disease etiology and in...
    Loading Comments...
    Show Resources